Shares Of Mylan Slightly Higher Following Launch Of Generic Drug

Shares of

were trading higher by 0.85 percent early Tuesday morning after the company

the launch of Linezolid Tablets, 600 mg. Linezolid is a generic version of

's Zyvox Tablets and is intended for adults and children for the treatment of certain infections caused by susceptible Gram-positive bacteria. Mylan noted that it has already received final approval from the US Food and Drug Administration. The company added that Linezolid Tablets had US sales of approximately $457.8 million for the 12 months ending September 30, 2015, according to IMS Health.